{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:35:26Z","timestamp":1790620526363,"version":"4.1.0"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T00:00:00Z","timestamp":1636675200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Chronic pulmonary aspergillosis (CPA) has a wide spectrum of illnesses depending on the progression of the disease and comorbid conditions. However, there is an inadequacy of investigations regarding clinical, laboratory, risk factor and prognostic data on CPA. The current study is aimed to consider the clinical manifestations, risk factors and outcomes of CPA.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methodology<\/jats:title>\n<jats:p>Retrospective records of all patients with a confirmed diagnosis of CPA who sought treatment at Gulab Devi Chest Hospital Lahore, Pakistan from January 2017 to December 2019 were evaluated. Data regarding demographics, clinical manifestations, comorbidities, radiographic and microbiological findings, length of hospital stay (LOS) and intensive care unit (ICU) admission was collected and analyzed to identify the factors associated with mortality. The independent factors associated with mortality were also identified by appropriate analyses.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>A total of 218 CPA patients were included in this study. The mean age was 45.75 \u00b1 6.26 years. Of these, 160 (73.4%) were male, and 65 (29.8%) had diabetes. The mean LOS was 18.5 \u00b1 10.9 days. The most common type of CPA was simple aspergilloma (56%) followed by chronic cavitary pulmonary aspergillosis (CCPA) (31.2%). About one half of the patients had a history of pulmonary tuberculosis (TB) and treatment response rates were low in patients with active TB. The overall mortality rate was 27.1%. ICU admission was required for 78 (35.8%) patients. Diabetes mellitus (DM), hematological malignancies and chronic kidney disease (CKD) were the common underlying conditions predicting a poor outcome. Mean LOS, hematological malignancies, consolidation and ICU admission were identified as the independent factors leading to mortality.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>CPA had a significant association with TB in the majority of cases. Treatment response rates in cases with active TB were comparatively low. Cases with high mean LOS, hematological malignancies, consolidation, ICU admission, CKD and DM experienced poor outcomes. High mean LOS, hematological malignancies, consolidation and ICU stay were identified as independent risk factors for mortality. Future large prospective studies, involving aspergillus specific immunoglobulin G (IgG) antibody testing, are required for a better understanding of CPA in Pakistan.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0259766","type":"journal-article","created":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T18:30:46Z","timestamp":1636741846000},"page":"e0259766","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":21,"title":["Clinical manifestations, associated risk factors and treatment outcomes of Chronic Pulmonary Aspergillosis (CPA): Experiences from a tertiary care hospital in Lahore, Pakistan"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8582-4249","authenticated-orcid":true,"given":"Waqas","family":"Akram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Bilal","family":"Ejaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tauqeer Hussain","family":"Mallhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Azhar bin","family":"Syed Sulaiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amer Hayat","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,11,12]]},"reference":[{"issue":"6","key":"pone.0259766.ref001","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1378\/chest.121.6.1988","article-title":"The clinical spectrum of pulmonary aspergillosis","volume":"121","author":"AO Soubani","year":"2002","journal-title":"Chest"},{"issue":"1","key":"pone.0259766.ref002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12890-016-0276-3","article-title":"Aspergillus nodules; another presentation of chronic pulmonary aspergillosis","volume":"16","author":"EG Muldoon","year":"2016","journal-title":"BMC pulmonary medicine"},{"issue":"4","key":"pone.0259766.ref003","doi-asserted-by":"crossref","first-page":"e0193732","DOI":"10.1371\/journal.pone.0193732","article-title":"Twelve-month clinical outcomes of 206 patients with chronic pulmonary aspergillosis","volume":"13","author":"F Bongomin","year":"2018","journal-title":"PloS one"},{"issue":"Supplement_3","key":"pone.0259766.ref004","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.1086\/376526","article-title":"Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review","volume":"37","author":"DW Denning","year":"2003","journal-title":"Clinical infectious diseases"},{"key":"pone.0259766.ref005","doi-asserted-by":"crossref","first-page":"864","DOI":"10.2471\/BLT.11.089441","article-title":"Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis","volume":"89","author":"DW Denning","year":"2011","journal-title":"Bulletin of the World Health Organization"},{"issue":"3","key":"pone.0259766.ref006","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1183\/09031936.00226911","article-title":"Global burden of chronic pulmonary aspergillosis complicating sarcoidosis","volume":"41","author":"DW Denning","year":"2013","journal-title":"European Respiratory Journal"},{"issue":"165","key":"pone.0259766.ref007","doi-asserted-by":"crossref","first-page":"165rv13","DOI":"10.1126\/scitranslmed.3004404","article-title":"Hidden killers: human fungal infections","volume":"4","author":"GD Brown","year":"2012","journal-title":"Science translational medicine"},{"issue":"4","key":"pone.0259766.ref008","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/jof3040057","article-title":"Global and multi-national prevalence of fungal diseases\u2014estimate precision","volume":"3","author":"F Bongomin","year":"2017","journal-title":"Journal of fungi"},{"key":"pone.0259766.ref009","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.meegid.2019.02.029","article-title":"Genetic diversity of multidrug-resistant Mycobacterium tuberculosis isolates in Punjab, Pakistan","volume":"72","author":"Z Baku\u0142a","year":"2019","journal-title":"Infection, Genetics and Evolution"},{"issue":"2","key":"pone.0259766.ref010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3390\/jof6020041","article-title":"Underlying Conditions and Clinical Spectrum of Chronic Pulmonary Aspergillosis (CPA): An Experience from a Tertiary Care Hospital in Karachi, Pakistan","volume":"6","author":"N Iqbal","year":"2020","journal-title":"Journal of Fungi"},{"issue":"6","key":"pone.0259766.ref011","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s10096-017-2919-6","article-title":"Serious fungal infections in Pakistan","volume":"36","author":"K Jabeen","year":"2017","journal-title":"European Journal of Clinical Microbiology & Infectious Diseases"},{"issue":"1","key":"pone.0259766.ref012","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2016-000155","article-title":"Clinical manifestations and outcomes of pulmonary aspergillosis: experience from Pakistan","volume":"3","author":"N Iqbal","year":"2016","journal-title":"BMJ open respiratory research"},{"issue":"1","key":"pone.0259766.ref013","first-page":"86","article-title":"Colonization and infection","volume":"67","author":"A Dani","year":"2014","journal-title":"Central European journal of urology"},{"issue":"1","key":"pone.0259766.ref014","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1183\/13993003.00583-2015","article-title":"Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management","volume":"47","author":"DW Denning","year":"2016","journal-title":"European Respiratory Journal"},{"key":"pone.0259766.ref015","doi-asserted-by":"crossref","DOI":"10.1002\/9781118520055","volume-title":"Identification of pathogenic fungi","author":"CK Campbell","year":"2013"},{"issue":"5","key":"pone.0259766.ref016","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1111\/j.1475-6773.2005.00444.x","article-title":"Measuring diagnoses: ICD code accuracy","volume":"40","author":"KJ O\u2019malley","year":"2005","journal-title":"Health services research"},{"issue":"12","key":"pone.0259766.ref017","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.2169\/internalmedicine.53.1578","article-title":"Clinical features of pulmonary aspergillosis associated with interstitial pneumonia","volume":"53","author":"F Kurosaki","year":"2014","journal-title":"Internal Medicine"},{"issue":"1","key":"pone.0259766.ref018","doi-asserted-by":"crossref","first-page":"92","DOI":"10.5958\/j.2319-5886.3.1.019","article-title":"Prevalence and fungal profile of pulmonary aspergillosis in immunocompromised and immunocompetent patients of a tertiary care hospital","volume":"3","author":"P Ved","year":"2014","journal-title":"International Journal of Medical Research & Health Sciences"},{"key":"pone.0259766.ref019","volume-title":"Seminars in Respiratory and Critical Care Medicine; 2008","author":"GR Thompson","year":"1994"},{"issue":"3","key":"pone.0259766.ref020","first-page":"242","article-title":"Pulmonary aspergillosis: clinical presentation, diagnostic tests, management and complications","volume":"16","author":"R Sherif","year":"2010","journal-title":"Current opinion in pulmonary medicine"},{"issue":"4","key":"pone.0259766.ref021","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00005792-200007000-00006","article-title":"Invasive aspergillosis disease spectrum, treatment practices, and outcomes","volume":"79","author":"TF Patterson","year":"2000","journal-title":"Medicine"},{"issue":"4","key":"pone.0259766.ref022","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1183\/09031936.00054810","article-title":"Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma","volume":"37","author":"N Smith","year":"2011","journal-title":"European Respiratory Journal"},{"issue":"6","key":"pone.0259766.ref023","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0954-6111(05)80051-4","article-title":"Chronic necrotizing pulmonary aspergillosis and pulmonary phycomycosis in cystic fibrosis","volume":"88","author":"C Grahame-Clarke","year":"1994","journal-title":"Respiratory medicine"},{"issue":"1","key":"pone.0259766.ref024","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jss.2011.08.019","article-title":"Murray and Nadel\u2019s Textbook of Respiratory Medicine","volume":"173","author":"V Nomellini","year":"2012","journal-title":"Journal of Surgical Research"},{"issue":"3","key":"pone.0259766.ref025","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/thoraxjnl-2014-206291","article-title":"The clinical spectrum of pulmonary aspergillosis","volume":"70","author":"C Kosmidis","year":"2015","journal-title":"Thorax"},{"issue":"6","key":"pone.0259766.ref026","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1469-0691.2005.01143.x","article-title":"Invasive pulmonary aspergillosis in chronic obstructive pulmonary disease: an emerging fungal pathogen","volume":"11","author":"F Ader","year":"2005","journal-title":"Clinical Microbiology and Infection"},{"key":"pone.0259766.ref027","article-title":"Chronic pulmonary aspergillosis in patients with post-tuberculosis bronchiectasis","author":"O Munteanu","year":"2018","journal-title":"Eur Respiratory Soc"},{"issue":"3","key":"pone.0259766.ref028","doi-asserted-by":"crossref","first-page":"1801184","DOI":"10.1183\/13993003.01184-2018","article-title":"Chronic pulmonary aspergillosis commonly complicates treated pulmonary tuberculosis with residual cavitation","volume":"53","author":"ID Page","year":"2019","journal-title":"European Respiratory Journal"},{"issue":"214","key":"pone.0259766.ref029","first-page":"2","article-title":"Aspergilloma in Active Tuberculosis: A Case Report","volume":"3","author":"W Dar","year":"2015","journal-title":"J Gen Practice"},{"issue":"1","key":"pone.0259766.ref030","first-page":"55","article-title":"Co-existence of HIV, active tuberculosis and aspergilloma in a single individual\u2014a case report","volume":"60","author":"UP Singh","year":"2013","journal-title":"The Indian journal of tuberculosis"},{"issue":"11","key":"pone.0259766.ref031","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1136\/thx.39.11.862","article-title":"Management of pulmonary aspergilloma in the presence of active tuberculosis","volume":"39","author":"A Adeyemo","year":"1984","journal-title":"Thorax"},{"key":"pone.0259766.ref032","author":"A Shahnazi","year":"2010","journal-title":"Is Pulmonary Aspergillosis Common in Diabetes Mellitus Patients?"},{"issue":"7","key":"pone.0259766.ref033","doi-asserted-by":"crossref","first-page":"771","DOI":"10.5588\/ijtld.19.0119","article-title":"Tackling diabetes mellitus and tuberculosis: a new Union guide on the management of diabetes-tuberculosis","volume":"23","author":"Y Lin","year":"2019","journal-title":"The International Journal of Tuberculosis and Lung Disease"},{"issue":"3","key":"pone.0259766.ref034","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/thoraxjnl-2012-201756","article-title":"Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes","volume":"68","author":"ME Jim\u00e9nez-Corona","year":"2013","journal-title":"Thorax"},{"issue":"12","key":"pone.0259766.ref035","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S1473-3099(09)70282-8","article-title":"Tuberculosis and diabetes mellitus: convergence of two epidemics","volume":"9","author":"KE Dooley","year":"2009","journal-title":"The Lancet infectious diseases"},{"issue":"6","key":"pone.0259766.ref036","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02396-2016","article-title":"Chronic pulmonary aspergillosis complicating sarcoidosis","volume":"49","author":"Y Uzunhan","year":"2017","journal-title":"European Respiratory Journal"},{"issue":"8","key":"pone.0259766.ref037","doi-asserted-by":"crossref","DOI":"10.3201\/eid2408.171312","article-title":"Case definition of chronic pulmonary aspergillosis in resource-constrained settings","volume":"24","author":"DW Denning","year":"2018","journal-title":"Emerging infectious diseases"},{"issue":"4","key":"pone.0259766.ref038","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s12281-017-0304-7","article-title":"The management of chronic pulmonary aspergillosis: the UK national aspergillosis centre approach","volume":"11","author":"F Maghrabi","year":"2017","journal-title":"Current fungal infection reports"},{"issue":"9","key":"pone.0259766.ref039","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.5588\/ijtld.17.0060","article-title":"Chronic pulmonary aspergillosis as a cause of smear-negative TB and\/or TB treatment failure in Nigerians","volume":"21","author":"R Oladele","year":"2017","journal-title":"The International Journal of Tuberculosis and Lung Disease"},{"issue":"8","key":"pone.0259766.ref040","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3109\/13693786.2013.806826","article-title":"Clinical characteristics and treatment outcomes of chronic pulmonary aspergillosis","volume":"51","author":"BW Jhun","year":"2013","journal-title":"Medical Mycology"},{"issue":"5","key":"pone.0259766.ref041","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1016\/j.jinf.2005.08.022","article-title":"The efficacy and tolerability of voriconazole in the treatment of chronic cavitary pulmonary aspergillosis","volume":"52","author":"LR Jain","year":"2006","journal-title":"Journal of Infection"},{"issue":"5","key":"pone.0259766.ref042","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1378\/chest.06-2441","article-title":"Treatment of chronic pulmonary aspergillosis by voriconazole in nonimmunocompromised patients","volume":"131","author":"J Camuset","year":"2007","journal-title":"Chest"},{"issue":"5","key":"pone.0259766.ref043","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.rmed.2012.01.014","article-title":"Clinical characteristics and prognosis of chronic pulmonary aspergillosis","volume":"106","author":"H Ohba","year":"2012","journal-title":"Respiratory medicine"},{"issue":"1","key":"pone.0259766.ref044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-200161001-00001","article-title":"An overview of fungal infections","volume":"61","author":"G Garber","year":"2001","journal-title":"Drugs"},{"issue":"2","key":"pone.0259766.ref045","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF01967060","article-title":"Fungal infections in cancer patients: an international autopsy survey","volume":"11","author":"G Bodey","year":"1992","journal-title":"European Journal of Clinical Microbiology and Infectious Diseases"},{"key":"pone.0259766.ref046","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/978-1-4614-3764-2_51","volume-title":"Neoplastic Diseases of the Blood","author":"M Nucci","year":"2013"},{"issue":"1","key":"pone.0259766.ref047","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1164\/rccm.2008-740ST","article-title":"An official American Thoracic Society statement: treatment of fungal infections in adult pulmonary and critical care patients","volume":"183","author":"AH Limper","year":"2011","journal-title":"American journal of respiratory and critical care medicine"},{"key":"pone.0259766.ref048","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.3389\/fmicb.2018.02223","article-title":"Evaluation of galactomannan testing, the Aspergillus-specific lateral-flow device test and levels of cytokines in bronchoalveolar lavage fluid for diagnosis of chronic pulmonary aspergillosis","volume":"9","author":"HJ Salzer","year":"2018","journal-title":"Frontiers in Microbiology"},{"issue":"5","key":"pone.0259766.ref049","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jinf.2014.01.005","article-title":"Serum galactomannan antigen test for the diagnosis of chronic pulmonary aspergillosis","volume":"68","author":"B Shin","year":"2014","journal-title":"Journal of Infection"},{"issue":"6","key":"pone.0259766.ref050","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1128\/JCM.02497-16","article-title":"Usefulness of two Aspergillus PCR assays and Aspergillus galactomannan and \u03b2-d-glucan testing of Bronchoalveolar lavage fluid for diagnosis of chronic pulmonary aspergillosis","volume":"55","author":"N Urabe","year":"2017","journal-title":"Journal of clinical microbiology"},{"key":"pone.0259766.ref051","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.3389\/fmicb.2018.01810","article-title":"Recent advances in diagnosing chronic pulmonary aspergillosis","volume":"9","author":"T Takazono","year":"2018","journal-title":"Frontiers in microbiology"},{"key":"pone.0259766.ref052","doi-asserted-by":"crossref","DOI":"10.3389\/978-2-88945-846-2","volume-title":"Diagnostic Approaches for Aspergillus Infections","author":"J Prattes","year":"2019"},{"key":"pone.0259766.ref053","author":"JL Longe","year":"2015","journal-title":"The Gale encyclopedia of medicine"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0259766","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T18:31:38Z","timestamp":1636741898000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0259766"}},"subtitle":[],"editor":[{"given":"Muhammad","family":"Adrish","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,11,12]]},"references-count":53,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0259766","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,12]]}}}